M&A Deal Summary

Perrigo Company Acquires Omega Pharma NV

On November 4, 2014, Perrigo Company acquired medical products company Omega Pharma NV for 3.6B EUR

Acquisition Highlights
  • This is Perrigo Company’s 9th transaction in the Medical Products sector.
  • This is Perrigo Company’s largest (disclosed) transaction.
  • This is Perrigo Company’s 1st transaction in Belgium.

M&A Deal Summary

Date 2014-11-04
Target Omega Pharma NV
Sector Medical Products
Buyer(s) Perrigo Company
Deal Type Add-on Acquisition
Deal Value 3.6B EUR

Target

Omega Pharma NV

Nazareth, Belgium
Omega Pharma NV is a healthcare company. Omega Pharma provides medicines, health and personal care that can be purchased at the pharmacy.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Perrigo Company

Dublin 2, Ireland

Category Company
Founded 1887
Sector Life Science
Employees9,140
Revenue 4.7B USD (2023)
DESCRIPTION
Entrance to a Perrigo facility in Duncan, South Carolina.
Entrance to a Perrigo facility in Duncan, South Carolina.

Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo Company was founded in 1887 and is based in Dublin, Ireland.


DEAL STATS #
Overall 22 of 31
Sector (Medical Products) 9 of 10
Type (Add-on Acquisition) 18 of 23
Country (Belgium) 1 of 1
Year (2014) 2 of 2
Size (of disclosed) 1 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-28 OTC Products

Grand Bay, Mauritius

OTC Products are primarily sold through the mass retail channel and include the Herron® range of analgesics, vitamins and supplements. This basket of products is expected to generate at least $20 million in annual revenue.

Buy $51M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-22 Naturwohl Pharma

Grafelfing, Germany

Naturwohl Pharma GmbH (Yokebe) is a provider of dietary supplement brand Yokebe.

Buy -